Patient-focused, physician-inspired solutions.
Feedback from customers and patients, are the building blocks for this next generation product, including:
• |
MammoSite and MammoSite ML systems are capable of meeting all dosimetric parameters of Section 13.1.4 of the
NSABP-39/RTOG 0413 protocol amended in April 2011.
|
• |
New inflation diameter (3.5 cm - 5 cm) and multiple offset lumens allow for treatment of a broad spectrum of patients.
|
• |
Six-year ASBS Registry data shows excellent/good cosmetic results in 90.4% of cases. |
|
Thousands of women have confronted the challenges of breast cancer & fought it with MammoSite targeted radiation therapy. Connect your patients with these women and their impactful, heartwarming stories at Voices of MammoSite.
|